In Silico Insight into Potent of Anthocyanin Regulation of FKBP52 to Prevent Alzheimer’s Disease

ASIA unversity > 管理學院 > 國際企業學系 > 期刊論文 > Item 310904400/79847

請使用永久網址來引用或連結此文件: http://asiair.asia.edu.tw/ir/handle/310904400/79847

題名:	In Silico Insight into Potent of Anthocyanin Regulation of FKBP52 to Prevent Alzheimer’s Disease
作者:	Tzu-Chieh Hung;Tung-Ti Chang;Ming-Jen Fan;Cheng-Chun Lee;Calvin Yu-Chian Chen
貢獻者:	生物科技學系
日期:	2014-05
上傳時間:	2014-06-05 04:18:30 (UTC+0)
摘要:	Alzheimer’s disease (AD) is caused by the hyperphosphorylation of Tau protein aggregation. FKBP52 (FK506 binding protein 52) has been found to inhibit Tau protein aggregation. This study found six different kinds of anthocyanins that have high binding potential. After analyzing the docking positions, hydrophobic interactions, and hydrogen bond interactions, several amino acids were identified that play important roles in protein and ligand interaction. The proteins’ variation is described using eigenvectors and the distance between the amino acids during a molecular dynamics simulation (MD). This study investigates the three loops based around Glu85, Tyr113, and Lys121—all of which are important in inducing FKBP52 activation. By performing a molecular dynamic simulation process between unbound proteins and the protein complex with FK506, it was found that ligand targets that docked onto the FK1 domain will decrease the distance between Glu85/Tyr113 and Glu85/Lys121. The FKBP52 structure variation may induce FKBP52 activation and inhibit Tau protein aggregation. The results indicate that anthocyanins might change the conformation of FKBP52 during binding. In addition, the purple anthocyanins, such as cyanidin-3-glucoside and malvidin-3-glucoside, might be better than FK506 in regulating FKBP52 and treating Alzheimer’s disease.
關聯:	Evidence-based Complementary and Alternative Medicine
顯示於類別:	[國際企業學系] 期刊論文

文件中的檔案:

檔案	大小	格式	瀏覽次數
index.html	0Kb	HTML	443	檢視/開啟

在ASIAIR中所有的資料項目都受到原著作權保護.

資料載入中.....